Michael ORourke - CardieX Non-Executive Director
Director
Dr. Michael ORourke, M.D. is no longer as NonExecutive Director of the Company, effective December 2017. He is the Cofounder and inventor of the core technology for the SphygmoCor system. Coauthor of the standard reference textbook McDonalds Blood Flow in Arteries. He also serves on the editorial Boards for the American Heart Association journal Hypertension, and on the editorial Boards of Journal of Hypertension, American Journal of Hypertension and Journal of American Society of Hypertension.
| Age | 75 |
| Professional Marks | Ph.D |
| Phone | 61 2 9874 8761 |
| Web | http://cardiex.com |
CardieX Management Efficiency
The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.97) %, meaning that it generated substantial loss on money invested by shareholders. CardieX's management efficiency ratios could be used to measure how well CardieX manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. CardieX Limited has a current ratio of 1.67, which is within standard range for the sector. Debt can assist CardieX until it has trouble settling it off, either with new capital or with free cash flow. So, CardieX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardieX Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardieX to invest in growth at high rates of return. When we think about CardieX's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Joseph Alvarado | Sea | 62 | |
| Chen Heng | Sea | N/A | |
| Maureen Morrison | Asbury Automotive Group | 66 | |
| Anthony Comper | Sea | 69 | |
| Elizabeth Temple | ScanSource | 53 | |
| Yuxin Ren | Sea | 43 | |
| Mary Gentry | ScanSource | N/A | |
| Gang Ye | Sea | 44 | |
| Hou Tianyu | Sea | 46 | |
| John Reilly | ScanSource | 69 | |
| Austin Adams | Sea | 71 | |
| Tao Zhang | Sea | N/A | |
| Michael Phelps | Sea | 67 | |
| Joel Alsfine | Asbury Automotive Group | 51 | |
| Saar Gillai | Semtech | 51 | |
| Clarence Cazalot | Sea | 64 | |
| Miranda Hubbs | Sea | 48 | |
| Pamela Carter | Sea | 65 | |
| Rodolpho Cardenuto | Semtech | N/A | |
| Michael Morris | Sea | 68 | |
| Scott Thompson | Asbury Automotive Group | 57 | |
Management Performance
| Return On Equity | -48.97 | |||
| Return On Asset | -16.43 |
CardieX Limited Leadership Team
Elected by the shareholders, the CardieX's board of directors comprises two types of representatives: CardieX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardieX. The board's role is to monitor CardieX's management team and ensure that shareholders' interests are well served. CardieX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardieX's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rhonda Welch, Vice President of Global Marketing | ||
| David Brookes, Independent Non-Executive Director | ||
| Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd | ||
| Niall Cairns, Non-Executive Director | ||
| Chris Dax, Vice President - Operations | ||
| Peter Jenkins, Independent Non-Executive Director | ||
| Craig Cooper, CEO, Executive Director | ||
| Duncan Ross, CEO, Managing Director, Executive Director | ||
| Randall Nelson, Independent Non-Executive Director | ||
| Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc | ||
| Michael ORourke, Non-Executive Director | ||
| Donal ODwyer, Independent Non-Executive Chairman of the Board | ||
| Peter Manley, CFO, Company Secretary |
CardieX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CardieX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -48.97 | |||
| Return On Asset | -16.43 | |||
| Profit Margin | (61.97) % | |||
| Operating Margin | (48.59) % | |||
| Current Valuation | 32.61 M | |||
| Shares Outstanding | 532.82 M | |||
| Shares Owned By Insiders | 46.84 % | |||
| Price To Earning | (1.47) X | |||
| Price To Book | 5.00 X | |||
| Price To Sales | 4.20 X |
Pair Trading with CardieX
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CardieX position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CardieX will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Advanced Micro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Advanced Micro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Advanced Micro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Advanced Micro Devices to buy it.
The correlation of Advanced Micro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Advanced Micro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Advanced Micro Devices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Advanced Micro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in CardieX OTC Stock
If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |